EXECUTIVE ENGAGEMENTS
POOL
489
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
98
Interactions with Platform & by Email
PARTICIPANTS
22
Unique # Participated
VALIDATIONS
8
Responses Validated*
COMPANIES
44
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
74
PAGES
148
EDITION
8
PRICE
USD 4950
CODE
MCP16589
*Engagement stats are ongoing and dynamic
Login to access data silos
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Microbiome Sequencing Services estimated at US$931.8 Million in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 17.8% over the analysis period 2020-2027. Synthesis, one of the segments analyzed in the report, is projected to record a 16.6% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ligation segment is readjusted to a revised 14.6% CAGR for the next 7-year period.
The Microbiome Sequencing Services market in the U.S. is estimated at US$275.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$507.9 Million by the year 2027 trailing a CAGR of 17.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.6% and 15.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.
In the global Pyrosequencing segment, USA, Canada, Japan, China and Europe will drive the 21.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$110.9 Million in the year 2020 will reach a projected size of US$443.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$356.6 Million by the year 2027.
SELECT PLAYERS
Clinical-Microbiomics A/S; Diversigen, Inc.; GATC Biotech AG; Second Genome
SEGMENTS
» End-Use (Pharmaceutical, Academic & Research Institutes, Biotech) » Technique (Synthesis, Ligation, Pyrosequencing, Sanger Sequencing, Other Techniques)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027 |
| World Current & Future Analysis for Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Ligation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Ligation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Pyrosequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Pyrosequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Sanger Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Sanger Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| World Current & Future Analysis for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World 7-Year Perspective for Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| USA Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| Canada Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| Japan Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| China Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027 |
| Europe Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| Europe Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| France Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| Germany Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| Italy Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| UK Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2020 & 2027 |
| Rest of World Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 44 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com